Sickle Cell Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
"Who might be able to join this trial:
- People who are receiving treatment or specialist medical advice for a non-cancerous blood disorder, or for a blood condition known as myelodysplastic syndrome (MDS) or myeloproliferative neoplasm (MPN).
- Biological (blood-related) family members of someone who meets the first criterion above — this includes parents, children, siblings, grandparents, aunts, uncles, cousins, and similar relatives.
Who may not be able to join:
- There are no listed exclusion criteria for this trial — the trial site can confirm whether a specific individual meets the requirements.
Important: Always verify eligibility with the trial site directly before applying."
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Marcin Wlodarski, MD, PhD, St. Jude Children's Research Hospital
Phone: 888-226-4343
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Percent of participants who agree to participate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.